Use App
New
Connect your Agent
Trending
News
Earnings
All
DIA
0.36%
SPY
0.45%
QQQ
0.84%
Trending
NVDA
5.59%
WEN
13.27%
CRM
13.97%
OKTA
21.34%
NLST
11.97%
CRWD
9.46%
BCH
0.28%
POET
2.97%
NOW
3.67%
AVEX
5.10%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
BTSG
news
Exchange:
NASDAQ
·
Updated 09:15 PM EDT
News
all
press releases
Here's Why Investors Should Retain Humana Stock for Now
HUM benefits from Medicare Advantage growth, CenterWell expansion and strong cash generation, but rising costs and debt remain concerns.
Zacks
Share to Feed
More News
Best Momentum Stocks to Buy for August 26th
BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2026.
Zacks
New Strong Buy Stocks for August 26th
BTSG, OPHC, HRTG, UMC and MTG have been added to the Zacks Rank #1 (Strong Buy) List on August 26th, 2026.
Zacks
Zacks Industry Outlook CareDx, BrightSpring and PACS
CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.
Zacks
Zacks.com featured highlights Sandisk, Celestica and BrightSpring
Sandisk, Celestica and BrightSpring have been highlighted in this Screen of The Week article.
Zacks
Sandisk & 2 Profitable Stocks to Buy Now for Explosive Upside
Sandisk, Celestica and BrightSpring rank among profitable stocks, with strong net income ratios and earnings growth supporting upside.
Zacks
3 Medical Service Stocks Resilient Amid Persistent Workforce Shortage
CareDx, BrightSpring and PACS Group are positioned for growth as digital health expands and workforce shortages reshape medical services.
Zacks
3 Non-Tech Thriving Nasdaq Stocks Enabling Its Northward Move in 2026
IBKR, ROKU and BTSG are thriving on Nasdaq, backed by product expansion, streaming growth and care migration.
Zacks
Here's Why Encompass Health Can Be a Smart Addition to Your Portfolio
EHC's rising demand, higher patient acuity and hospital expansion support growth, while rising expenses and debt remain key risks.
Zacks
BrightSpring Stock Up Nearly 59% YTD: Can Its Growth Story Continue?
BTSG's nearly 59% YTD surge is backed by 23% revenue growth, rising margins and expansion in specialty pharmacy and home-based care.
Zacks
1
2
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile